Chemed (CHE) Azione Prezzo
Chemed Prezzo
Il fatturato è cresciuto a un tasso composto del 4,9% annuo negli ultimi 19 anni, raggiungendo 2,53 miliardi USD. L'utile per azione è cresciuto del 12,7% all'anno negli ultimi 19 anni. Il margine netto di Chemed si attesta al 10,5%, in calo rispetto al 12,6% di alcuni anni fa. Chemed offre attualmente un rendimento da dividendo di circa il 0,44%. Il payout ratio è pari a circa il 12% degli utili. Il dividendo è cresciuto del 12,4% all'anno negli ultimi 19 anni. Gli analisti fissano un target di prezzo mediano di 554,00 USD, ovvero il 11,5% sopra il prezzo attuale. Su 8 analisti, 4 valutano il titolo come acquisto — nel complesso un consenso Acquistare.
Chemed Prezzo delle azioni
Chemed Azione e analisi azionaria
Domande frequenti sull'azione Chemed
The business model of Chemed Corp focuses on providing end-of-life care services through its subsidiaries, VITAS Healthcare and Roto-Rooter. Chemed Corp operates in two segments: VITAS, which offers hospice services to patients with life-limiting illnesses, and Roto-Rooter, a leading provider of plumbing and drain cleaning services. VITAS prioritizes compassionate care, aiming to enhance quality of life for patients and support their families. Roto-Rooter, on the other hand, provides essential plumbing solutions, specializing in emergency repairs, maintenance, and installation services. Chemed Corp's business model emphasizes delivering high-quality and specialized services in the healthcare and plumbing sectors, positioning itself as a reliable and trusted provider.
Chemed Corp is primarily active in the healthcare and service industries.
The main competitors of Chemed Corp in the market include companies such as Amedisys Inc, Brookdale Senior Living Inc, and Encompass Health Corporation.
Chemed Corp is a renowned company with a rich history and compelling background. Established in 1970, Chemed Corp began as a provider of plumbing and drain cleaning services through its Roto-Rooter subsidiary. Over the years, it expanded its operations and diversified into healthcare services. Currently, Chemed Corp is a leading provider of hospice and palliative care services through its subsidiary, VITAS Healthcare. The corporation's commitment to exceptional patient care has earned it a stellar reputation in the healthcare industry. Chemed Corp continues to grow and flourish, upholding its core values and consistently delivering outstanding services to those in need.
Chemed Corp has achieved several significant milestones throughout its history. The company experienced strong growth and expanded its services, becoming a leader in the healthcare industry. Chemed Corp's subsidiary, VITAS Healthcare, has reached noteworthy achievements, including the provision of compassionate end-of-life care to thousands of patients and their families. Additionally, Chemed Corp successfully acquired and integrated various companies, enhancing its business portfolio and market presence. The company's commitment to innovation, quality care, and strategic acquisitions has contributed to its continued success and recognition within the industry.
Chemed Corp is primarily present in the United States.
Chemed Corp is a company known for exemplifying values of integrity, excellence, and innovation. With a strong corporate philosophy, Chemed prioritizes a customer-centric approach, constantly striving to meet and exceed their expectations. Their commitment to ethical practices and the highest standards in healthcare services distinguish them in the industry. Chemed also emphasizes the importance of fostering a positive work environment, valuing their employees and promoting professional growth. By consistently delivering exceptional results, Chemed reflects a dedication to long-term success and sustainable progress.
Gli analisti fissano attualmente un prezzo obiettivo medio di 554,00 USD per l’azione Chemed (mediana: 554,00 USD), pari a +11,5 % rispetto all’ultimo prezzo. Il consenso si basa su 8 giudizi di analisti.
8 analisti valutano attualmente l’azione Chemed: 4 raccomandano l’acquisto, 4 la tenuta e 0 la vendita. Per il 2026 gli analisti si aspettano per Chemed ricavi pari a 2,72 miliardi USD e un utile per azione di 27,67 USD.
Convertita al tasso di cambio attuale, l’azione Chemed quota 443,54 EUR (497,03 USD).
L’azione Chemed (CHE) è quotata su 2 borse, tra cui: NYSE (CHE), Frankfurt (CXM.F).
Chemed Corp is a US-based company operating in the hospice and drain cleaning sectors. It was founded in 1970 and is headquartered in Cincinnati, Ohio. Hospice services: Chemed Corp is the parent company of Vitas Healthcare, one of the largest hospice providers in the US. Vitas Healthcare offers a wide range of services for patients with life-threatening illnesses, including home care, support for family members and caregivers, pain therapy, and emotional support. Vitas Healthcare has a nationwide network of hospice centers and is a preferred hospice provider for Medicare, Medicaid, and private insurance companies. The company has also built partnerships with hospitals and nursing facilities to provide its customers access to top-quality care. Drain cleaning services: Chemed Corp also operates Roto-Rooter, one of the leading drain cleaning and plumbing companies in North America. The company offers a wide range of services, including pipe cleaning, sewer rehabilitation, and inspections of residential and commercial areas. Roto-Rooter is available 24/7 and offers emergency services. The company has also built a network of franchisees offering their services in multiple countries worldwide. Other business areas: In addition, Chemed Corp also operates milk production management consulting through its subsidiary Agri-Best. The company provides consulting services for dairy farms and assists with diets and feeding plans for dairy cows, among other services. Products: Chemed Corp offers a wide range of products for the hospice and drain cleaning sectors. For example, Vitas Healthcare offers medical supply products for customers and their environments, including respiratory aids, medical devices, and infusion pumps. Roto-Rooter offers plumbing products such as drain cleaners and pipes. Summary: Chemed Corp is a company operating in the hospice and drain cleaning sectors. The company offers a wide range of services and operates subsidiaries such as Vitas Healthcare and Roto-Rooter. Chemed Corp is also active in other business areas such as dairy management. The company offers a variety of products relevant to its different business sectors.
Il attesa fatturato di Chemed ammonta a 2,72 miliardi USD. Questo dato si basa sui dati finanziari attuali e riflette lo sviluppo commerciale dell'azienda.
Il attesa profitto di Chemed ammonta a 387,15 Mio. USD. L'utile netto riflette la redditività dell'azienda dopo la deduzione di tutti i costi.
Il rapporto prezzo/utili (P/E) di Chemed è attualmente 17,97. Il rapporto P/E confronta il prezzo attuale dell'azione con l'utile per azione e aiuta gli investitori a valutare la valutazione dell'azione Chemed.
Il rapporto prezzo/fatturato (P/S) di Chemed è attualmente 2,56. Il rapporto P/S confronta la capitalizzazione di mercato con il fatturato annuo e funge da indicatore di valutazione dell'azione Chemed.
Il Quality Score AlleAktien per Chemed è 6/10.
L'ISIN di Chemed è US16359R1032. L'ISIN (International Securities Identification Number) è un codice identificativo univoco a livello mondiale per i titoli.
Il WKN di Chemed è A0CBF4. Il WKN (Wertpapierkennnummer) è un codice identificativo tedesco a sei cifre per i titoli.
Il ticker di Chemed è CHE. Con questo simbolo di borsa vengono negoziate le azioni Chemed in borsa.
Azione Chemed
Gruppo di pari di Chemed
Chemed Ticker
Chemed FIGI
Altre metriche e analisi di Chemed in Deep Dive.
La nostra analisi azionaria dell'azione Chemed include importanti indicatori finanziari come il fatturato, l'utile, il P/E, il P/S, l'EBIT, oltre a informazioni sul dividendo. Inoltre, esaminiamo aspetti come le azioni, la capitalizzazione di mercato, il debito, il patrimonio netto e le passività di Chemed. Se state cercando informazioni più dettagliate su questi temi, sulle nostre sottopagine offriamo analisi approfondite: